Adela Raises $60M in Series A Funding finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
STOCKHOLM, March 15, 2021 /PRNewswire/ NeoDynamics AB (publ) presents an abstract on preclinical results with its novel biopsy system NeoNavia at the St Gallen International Breast Cancer Conference 2021, which is held March 17-21, 2021 in Vienna.
In light of this event, NeoDynamics and Redeye are organizing a parallel digital presentation for the financial markets on Wednesday March 17 at 13.00 - 14.00 CET where CEO Anna Eriksrud and Dr Kai-Uwe Schässburger, Head of Clinical Development & Medical Affairs, will present the results and comment on the launch of the product. The presentation will be followed by a Q&A session led by Redeye s analyst Oskar Bergman.
Invitation - NeoDynamics presents preclinical results on March 17 at 13 00 CET prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.